Immune mediators in the tumor microenvironment of prostate cancer.
about
Prognostic value of systemic immune-inflammation index in patients with gastric cancer.Cancer metastasis: issues and challengesSystemic immune-inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients.
P2860
Immune mediators in the tumor microenvironment of prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune mediators in the tumor microenvironment of prostate cancer.
@en
Immune mediators in the tumor microenvironment of prostate cancer.
@nl
type
label
Immune mediators in the tumor microenvironment of prostate cancer.
@en
Immune mediators in the tumor microenvironment of prostate cancer.
@nl
prefLabel
Immune mediators in the tumor microenvironment of prostate cancer.
@en
Immune mediators in the tumor microenvironment of prostate cancer.
@nl
P2093
P2860
P1476
Immune mediators in the tumor microenvironment of prostate cancer.
@en
P2093
Evan T Keller
Hernan Roca
Jill M Keller
Laurie K McCauley
P2860
P2888
P356
10.1186/S40880-017-0198-3
P50
P5008
P577
2017-03-14T00:00:00Z
P6179
1084253288